Categories: News

Stereotaxis to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022

ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2021 fourth quarter and full year ended December 31, 2021 on Thursday, March 3, 2022 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.

What: Stereotaxis fourth quarter and full year 2021 financial results conference call
   
When: Thursday, March 3, 2022 at 10:00 a.m. EST (7:00 a.m. PST)
   
Dial In Number: To access the live call, dial 866-409-1555 (US and Canada) or 313-209-4906 (International) and give the participant pass code 7498243.
   
Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/
   
Call Replay: A phone replay of the call will be available for one month beginning approximately two hours following the end of the call. To request access for a replay of the conference call, please click here.

About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com

Company Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Kimberly Peery
Chief Financial Officer

314-678-6100
investors@stereotaxis.com

Staff

Recent Posts

TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients

Vancouver, British Columbia--(Newsfile Corp. - December 8, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed"…

47 minutes ago

ECP Completes Massive Growth Financing to Accelerate Investment in AI Platform for Assisted Living

MILWAUKEE--(BUSINESS WIRE)--#assistedliving--ECP, the leading software platform purpose-built for assisted living, announced today a significant growth…

3 hours ago

Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process

Believes Belated Go-Shop Process Fails to Cure Fundamental Flaws in the Transaction’s Process, Timing, and…

3 hours ago

Welldoc Partners with CLEAR to Integrate Secure Identity Verification in AI-Powered Cardiometabolic Health Platform

Collaboration Advances CMS Health Tech Ecosystem Goals by Enabling Seamless, Secure Access to Health Data…

6 hours ago

Both Ends Believing Celebrates 15 Years of Transforming Global Child Welfare Through Technology

DALLAS, Dec. 4, 2025 /PRNewswire/ -- Both Ends Believing (BEB), a Dallas-based global nonprofit with…

6 hours ago

Sage introduces skilled nursing solution to Sage Core, expanding its unified platform across all levels of senior care

Skilled brings wireless-first nurse call, real-time insights, and integrated workflows, completing Sage Core's support across…

6 hours ago